FDA Inspection 756094 — Bioserv Corporation

Bioserv Corporation — FEI 2027352

The FDA completed an inspection of Bioserv Corporation on December 7, 2011 in San Diego, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 7, 2011
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
San Diego, CA (United States)

Citations

IDCFRDescription
145221 CFR 211.113(b)Validation lacking for sterile drug products
184421 CFR 211.84(d)(2)Establish reliability of supplier's C of A
357221 CFR 211.100(b)Procedure Deviations Recorded and Justified